About
The FIGO staging for ovarian cancer is a clinical tool designed for the classification and stratification of ovarian cancer severity. This system is crucial for determining the appropriate treatment strategy and for predicting patient prognosis. The primary components of this staging system are based on the extent of the tumor, its spread to other parts of the body, and the presence of malignant cells in the ascites or peritoneal washings. The staging ranges from Stage IA, where the tumor is limited to one ovary without any malignant cells in the ascites or peritoneal washings, to Stage IVB, which indicates distant metastasis excluding peritoneal metastasis and metastases to extra-abdominal organs. The FIGO staging for ovarian cancer takes into account whether the tumor is limited to one or both ovaries, the presence of surgical spill intraoperatively, capsule rupture before surgery, or tumor on the ovarian surface. It also considers the presence of malignant cells in the ascites or peritoneal washings, pelvic extension and/or implants on the uterus, fallopian tubes, or ovaries, and the spread to other pelvic intraperitoneal tissues. The system also includes stages for cytologically or histologically confirmed spread to the peritoneum outside the pelvis and/or metastasis to the retroperitoneal lymph nodes, as well as microscopic or macroscopic extrapelvic peritoneal involvement. The FIGO staging for ovarian cancer is a comprehensive system that provides a detailed assessment of the disease's extent, which is essential for guiding treatment decisions and estimating patient prognosis.